Long‐term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controls-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long‐term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controls

Published:2022-06-07 Issue:3 Volume:3 Page:949-953
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Winkelmann Nina¹,Schwarz Michaela²,Hildebrandt Bert¹,Henke Oliver¹,Bullinger Lars²,Na Il‐Kang²,Stintzing Sebastian¹,le Coutre Philipp¹^ORCID

Affiliation:

1. Department of Hematology, Oncology, and Cancer Immunology, Campus Charité Mitte Charité‐Universitätsmedizin Berlin Berlin Germany

2. Department of Hematology, Oncology, and Cancer Immunology, Campus Virchow‐Klinikum Charité‐ Universitätsmedizin Berlin Berlin Germany

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.502

Reference14 articles.

1. Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

2. Epidemiology of chronic myeloid leukaemia (CML)

3. Estimations of the increasing prevalence and plateau prevalence of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy

4. Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia

5. Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP